INTERIM CONSOLIDATED STATEMENTS OF CASH FLOW - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Cash flow from operating activities:
Net income	$ 12,117	$ 18,329
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	110,616	89,183
Amortization of above and below market leases	(9)	180
Amortization of deferred loan costs	2,259	1,978
Distributions from unconsolidated entity	1,381	600
Equity in net loss of unconsolidated entity	1,264	1,267
Equity-based compensation expense	14,167	10,956
Bad debt expense	455	5,072
Deferred tax expense (benefit)	141	(238)
Foreign currency remeasurement (income) loss	0	(159)
Changes in operating assets and liabilities
Rents and other receivables, net	(27,845)	(536)
Prepaid expenses	(2,066)	(1,259)
Due to/from affiliates, net	(3,865)	(1,085)
Other assets	(822)	(127)
Accounts payable and accrued liabilities	10,763	2,548
Advance rents, security deposits and other liabilities	140	2,374
Deferred income	29,679	4,283
Net cash provided by operating activities	148,375	133,366
Cash flow from investing activities:
Distribution of capital from unconsolidated entity	11,910	0
Acquisitions, net of cash acquired	(27,154)	(1,797)
Additions to property and equipment	(453,401)	(377,655)
Net cash used in investing activities	(468,645)	(379,452)
Cash flow from financing activities:
Credit facility proceeds	580,528	298,405
Credit facility repayments	(874,000)	(108,000)
Payment of deferred financing costs	0	(101)
Payment of preferred stock dividends	(14,090)	(14,090)
Payment of common stock dividends	(62,865)	(54,020)
Distribution to noncontrolling interests	(6,317)	(6,068)
Proceeds from exercise of stock options	1,979	882
Payment of tax withholdings related to equity-based awards	(2,485)	(3,327)
Principal payments on finance lease obligations	(1,349)	(1,275)
Mortgage principal debt repayments	0	(29)
Common stock issuance proceeds, net of costs	706,863	134,077
Net cash provided by financing activities	328,264	246,454
Effect of foreign currency exchange rates on cash and cash equivalents	(2,701)	453
Net change in cash and cash equivalents	5,293	821
Cash and cash equivalents, beginning of period	22,775	15,653
Cash and cash equivalents, end of period	28,068	16,474
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for interest	27,987	28,059
Noncash investing and financing activities:
Accrued capital additions	168,699	118,627
Net increase (decrease) in other assets/liabilities related to change in fair value of derivative contracts	21,398	(38,688)
Accrued equity issuance costs	0	405
Accrued preferred stock dividend	$ 5,938	$ 5,938